| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $2.6M | -25.3% |
| SG&A Expense | $2.3M | -58.7% |
| Operating Income | -$5.0M | +46.0% |
| Interest Expense | $255K | +253.2% |
| Net Income | -$9.9M | -1113.5% |
| EPS (Basic) | $0.00 | — |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.0M | +5.0% |
| Short-term Investments | $3.2M | +0.0% |
| Current Assets | $43.1M | -10.2% |
| Total Assets | $43.4M | -15.3% |
| Current Liabilities | $760K | +123.2% |
| Total Liabilities | $760K | +101.5% |
| Stockholders' Equity | $41.7M | -16.1% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | +56.8% |
| Capital Expenditures | $34K | +0.0% |
| Investing Cash Flow | $2.9M | -73.7% |
| Financing Cash Flow | $781K | -70.7% |
| Free Cash Flow | -$1.9M | +56.3% |